Refractory hematuria post actinic cystitis. Role of potassium alumen as treatment - Case Report
- 27 May 2022
- journal article
- Published by Peertechz Publications Private Limited in Global Journal of Medical and Clinical Case Reports
- Vol. 9 (2), 029-031
- https://doi.org/10.17352/2455-5282.000153
Abstract
Actinic cystitis hematuria is a frequent complication after pelvic radiotherapy, present in approximately 5% of patients exposed to this therapy. The management of these cases seems to be a challenge for today’s urologists. In this article, we present the case of a 73- year-old man diagnosed with actinic cystitis after pelvic radiotherapy and admitted to our service with a clinical picture of refractory macroscopic hematuria. During admission, the patient underwent multiple procedures and blood transfusions, without success in controlling hematuria. After a review of the literature, we chose to use Potassium Alum in the patient’s treatment. Under general anesthesia, we performed a cystoscopy with the evacuation of clots and subsequently infused a 1% solution of potassium alum into the bladder at a rate of 200 ml/h for 25 hours. Less than 24 hours after Alum infusion, there were no more clinical signs of hematuria, which remained until hospital discharge. After 6 months of treatment, the patient did not present another episode of hematuria.Keywords
This publication has 4 references indexed in Scilit:
- Safety and efficacy of intravesical alum for intractable hemorrhagic cystitis: a contemporary evaluationInternational braz j urol, 2016
- Management of radiation cystitisNature Reviews Urology, 2010
- The management of intractable haematuriaBJU International, 2000
- TREATMENT OF RADIATION INDUCED HEMORRHAGIC CYSTITIS WITH HYPERBARIC OXYGENJournal of Urology, 1998